|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| A61P 11/00 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 21/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| C07K 16/3084 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/56 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/92 | (2013.01) |
| (11) | Number of the document | 3484926 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17748642.0 |
| Date of filing the European patent application | 2017-07-17 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/000855 |
| Date | 2017-07-17 |
| (87) | Number | WO 2018/010846 |
| Date | 2018-01-18 |
| (30) | Number | Date | Country code |
| 16001564 | 2016-07-15 | EP |
| (72) |
TERME, Mickaël , FR
LE DOUSSAL, Jean-Marc , FR
DORVILLIUS, Mylene , FR
ASSOULINE, Brigitte , FR
|
| (73) |
OGD2 Pharma ,
3, chemin du Pressoir Chênaie, 44100 Nantes,
FR
|
| (54) | HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2) |
| HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2) |